Načítá se...

Beyond EGFR and ALK: targeting rare mutations in advanced non-small cell lung cancer

Lung cancer remains the leading cause of cancer-related death in men and women, despite its constantly declining rates in incidence and mortality in the developed world. The past decade has witnessed an unprecedented rise in the development of molecular targeted therapies in various types of tumors....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Transl Med
Hlavní autoři: Gkolfinopoulos, Stavros, Mountzios, Giannis
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5952024/
https://ncbi.nlm.nih.gov/pubmed/29862231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2018.04.28
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!